Evidence map›Paper›PMID 36928556›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2023

Distribution of [

Min Su Kang, Adjia Hamadjida, Dominique Bédard, Stephen G Nuara, Jim C Gourdon, Stephen Frey, Arturo Aliaga, Karen Ross, Robert Hopewell, Hussein Bdair and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Min Su KangTranslational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Montreal, QC, Canada.
Adjia HamadjidaNeurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, QC, H3A 2B4, Canada.
Dominique BédardNeurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, QC, H3A 2B4, Canada.
Stephen G NuaraComparative Medicine & Animal Resource Centre, McGill University, Montreal, QC, Canada.
Jim C GourdonComparative Medicine & Animal Resource Centre, McGill University, Montreal, QC, Canada.
Stephen FreyRogue Research Inc, Montreal, QC, Canada.
Arturo AliagaTranslational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Montreal, QC, Canada.
Karen RossNeurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, QC, H3A 2B4, Canada.
Robert HopewellMcConnell Brain Imaging Centre, Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada.
Hussein BdairNeurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, QC, H3A 2B4, Canada.
Axel MathieuDouglas Research Centre, McGill University, Montreal, QC, Canada.
Christine Lucas TardifNeurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, QC, H3A 2B4, Canada.
Jean-Paul SoucyNeurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, QC, H3A 2B4, Canada.
Gassan MassarwehNeurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, QC, H3A 2B4, Canada.
Pedro Rosa-NetoTranslational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Montreal, QC, Canada.
Philippe HuotNeurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, QC, H3A 2B4, Canada. philippe.huot@mcgill.ca.
Montreal Neurological Institute and Hospital · CAMcGill University · CARogue Research (Canada) · CASunnybrook Health Science Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

JNJ-42491293 is a metabotropic glutamate 2 (mGlu

Indexed as

CallithrixPositron-Emission TomographyAnimalsBinding SitesBrainProtein BindingRats[11C]-JNJ-42491293AZD8529MarmosetmGlu2 receptorPETPositive allosteric modulator

Identifiers

PMID36928556
OpenAlexW4327683667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.